Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1615 of 5804
-
New heart valve could spare patients from Open-Heart surgery
Disease control OngoingThe purpose of the study is to evaluate the safety and effectiveness of the PULSTA Transcatheter Pulmonary Valve (TPV) System for the treatment of congenital or acquired pulmonary valve stenosis and/or regurgitation who require pulmonary valve replacement.
Phase: NA • Sponsor: Taewoong Medical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could a menopause drug ease schizophrenia symptoms in women?
Symptom relief Recruiting nowTo study the effect of adjunctive bazedoxifene - a selective estrogen receptor modulator (SERM) in a double blind, placebo-controlled adjunctive study in the treatment of women with schizophrenia. All patients receive standardized antipsychotic medication.
Phase: PHASE4 • Sponsor: The Alfred • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Deep gene search aims to uncover why some young people get cancer
Knowledge-focused Recruiting now5 to 10% of cancers are due to the presence of a constitutional genetic alteration. It can be inherited from parents (family form) or by accident, in the first moments of life after fertilization (sporadic form). In both cases, this genetic alteration is constitutional and transm…
Phase: NA • Sponsor: Centre Georges Francois Leclerc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New study tests safer sedation for tiny lungs
Disease control CompletedThe investigators propose to evaluate premedication with Propofol compared to a control strategy including a placebo with a possible rescue treatment with ketamine to ensure pain control before LISA Procedure . Investigators hypothesize that sedation with Propofol is safe and non…
Phase: PHASE3 • Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Urine test may spare bladder cancer patients from frequent scopes
Diagnosis OngoingThis observational study evaluates the urine test BladMetrix for monitoring bladder cancer recurrences in people with non muscle invasive bladder cancer (NMIBC) who are in follow-up after surgery. The main goal is to evaluate the potential clinical utility of the BladMetrix test …
Sponsor: Oslo University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
New hope for rare kidney patients: Long-Term drug trial shows promise
Disease control Recruiting nowThis is an open-label extension study to evaluate the long-term efficacy, safety and tolerability of iptacopan in subjects with C3 glomerulopathy or idiopathic immune-complex-membranoproliferative glomerulonephritis
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New drug combo shows promise for rare nerve tumors
Disease control CompletedTo determine the clinical benefit rate of selumetinib in combination with sirolimus in patients with unresectable or metastatic neurofibromatosis type 1 (NF1) associated or sporadic MPNST.
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Blood test may predict cancer treatment success
Knowledge-focused OngoingThe PROPHETIC study is a prospective, multi-center, international clinical study aimed at developing an algorithm to predict patient outcomes. The study involves analyzing the proteomic profiles of patients undergoing therapy to assess the likelihood of clinical benefit from thei…
Sponsor: OncoHost Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Brain zaps show promise for gulf war Vets' pain and mood
Symptom relief CompletedThis study aims to look at the effectiveness of using repetitive transcranial magnetic stimulation (rTMS) in relieving pain and other co-morbid symptoms of Gulf War Illness.
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Can CBD help veterans overcome PTSD? new study puts it to the test.
Symptom relief CompletedThe trial will include a randomized control trial to evaluate the efficacy of using Cannabidiol (CBD), a non-intoxicating cannabinoid, as an adjunctive to Prolonged Exposure therapy (PE). The trial will compare PE + CBD to PE + placebo in a sample of 136 military Veterans with PT…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Can brain training beat Schizophrenia's 'Negative' symptoms?
Symptom relief OngoingThis project will conduct a confirmatory efficacy trial of two novel psychosocial interventions, Cognitive Enhancement Therapy and Enriched Supportive Therapy, for the treatment of persistent negative symptoms in schizophrenia.
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New drug shows promise for Sjögren's syndrome in Mid-Stage trial
Disease control CompletedThis study was to evaluate the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of multiple doses of CFZ533 (iscalimab) in patients with Sjögren's Syndrome (SjS).
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can a sleep-focused therapy calm bipolar symptoms?
Symptom relief CompletedCognitive Behavioral Therapy (CBT) is treatment of choice for insomnia. Many patients in psychiatric care have sleep problems including insomnia, but are rarely given the choice to participate in CBT to improve their sleep. Patients with Bipolar disorder is a patient group with h…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Blood cancer drug ASTX727 gets extended trial for ongoing patients
Disease control ENROLLING_BY_INVITATIONExtension study to provide ongoing long-term treatment with ASTX727 for participants who were benefitting from ASTX727 treatment in a previous Taiho (formerly Astex)-sponsored clinical study of ASTX727 (including, but not limited to ASTX727-01 \[NCT02103478\], ASTX727-02 \[NCT033…
Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New CAR-T therapy shows promise for lymphoma patients who relapsed after prior treatment
Disease control CompletedThis is a single-center, non-randomized and dose-escalation study to evaluate the safety and efficacy of C-CAR066 in treatment of r/r DLBCL who received CD19 CAR-T therapy.
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hormone pill cuts hot flashes in half for menopausal women
Symptom relief CompletedA two-part study designed to evaluate the effect of Estetrol (E4) 15 mg, 20 mg, or placebo on the severity and frequency of vasomotor symptoms (VMS) in the Efficacy Study Part and the safety of E4 20 mg in the Safety Study Part.
Phase: PHASE3 • Sponsor: Estetra • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Could a sleep medication curb nicotine cravings?
Symptom relief OngoingTobacco smoking continues to be the primary cause of preventable mortality in the United States. Despite the availability of smoking cessation aids, the majority of those trying to quit smoking end up relapsing. Thus, there is a strong need to evaluate alternative treatment targe…
Phase: PHASE1 • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Brain boot camp: can a memory-training program sharpen thinking in multiple sclerosis?
Symptom relief CompletedThe purpose of this research study is to investigate the effectiveness of a memory enhancement technique in persons with Multiple Sclerosis.
Phase: NA • Sponsor: Kessler Foundation • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Experimental drug plus radiation shows promise for recurrent gynecologic cancers
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of talazoparib in combination with radiation therapy and to see how well they work in treating patients with gynecologic cancers that have come back after previous treatment (recurrent). Talazoparib may stop the growth of …
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could migraine meds silence tinnitus? new trial investigates
Symptom relief CompletedTinnitus represents one of the most common and distressing otologic problems, and it causes various somatic and psychological disorders that interfere with the quality of life. In addition, it contributes significant costs to the healthcare system. However, the mechanisms of tinn…
Phase: PHASE4 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC